Latest Articles

Publication Date
Optimising Hormonal Therapy Before Declaring Failure in Endometriosis-Associated Pain.

Published: Sept. 24, 2025, midnight
Perioperative Anesthetic and Hormonal Considerations in a Patient With Anti-glutamic Acid Decarboxylase Encephalitis: A Case Report - Cureus

Perioperative Anesthetic and Hormonal Considerations in a Patient With Anti-glutamic Acid Decarboxylase Encephalitis: A Case Report Cureus

Published: Sept. 22, 2025, 4:46 p.m.
The endocrine aspects of endometriosis.

Endometriosis is a chronic gynecologic disease of reproductive-age women, causing menstrual pain and infertility. Endocrine and inflammatory mechanisms drive its development, with estrogen/progesterone imbalance contributing to extrauterine implantation and persistence …

Published: Sept. 22, 2025, midnight
Regulated cell death in endometrial diseases: from molecular mechanisms to targeted therapies.

Regulated cell death (RCD) is a fundamental biological process essential for tissue homeostasis and disease regulation. Increasing evidence has demonstrated that RCD plays a pivotal role in the pathogenesis of …

Published: Sept. 22, 2025, midnight
Perioperative Anesthetic and Hormonal Considerations in a Patient With Anti-glutamic Acid Decarboxylase Encephalitis: A Case Report.

Glutamic acid decarboxylase (GAD) is vital for gamma-aminobutyric acid (GABA) synthesis. Auto-antibodies against GAD deplete GAD levels and subsequently GABA, resulting in a hyper-excitatory state. A 41-year-old woman with anti-GAD …

Published: Sept. 22, 2025, midnight
Overall Survival After Hormonal Therapy vs Hysterectomy in Early Endometrial Cancer - The ASCO Post

Overall Survival After Hormonal Therapy vs Hysterectomy in Early Endometrial Cancer The ASCO Post

Published: Sept. 19, 2025, 2:31 p.m.
Dysregulation of Key Biological Processes in Endometriosis Pathophysiology.

Endometriosis is a typical disorder affecting the female reproductive system and is characterized by the presence of tissue resembling the endometrium both within and beyond the pelvic cavity. Unfortunately, the …

Published: Sept. 18, 2025, midnight
Tolerability and Shared Decision-Making in the Hormonal Management of Endometriosis-Associated Pain.

Background: The management of endometriosis-associated pain has traditionally focused on analgesic efficacy. However, with high-level evidence demonstrating therapeutic equivalence among principal hormonal classes, the paradigm has shifted towards a patient-centred …

Published: Sept. 18, 2025, midnight
How long does combined hormonal therapy suppress AMH levels in women with endometriomas? Results from an exploratory analysis of a clinical trial.

Lower Anti-Müllerian hormone (AMH) levels have been observed in women with ovarian endometriomas (OMA) undergoing combined hormonal contraceptive (CHC) therapy. However, the extent and timing of AMH recovery after CHC …

Published: Sept. 16, 2025, midnight
GnRH Agonist Pretreatment in Hormonal Endometrial Preparation: A Comparison of Two Protocols for Frozen Embryo Transfer Outcomes - Frontiers

GnRH Agonist Pretreatment in Hormonal Endometrial Preparation: A Comparison of Two Protocols for Frozen Embryo Transfer Outcomes Frontiers

Published: Sept. 15, 2025, 2:17 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!